No Bio Specified
No Bio Specified
No Bio Specified
No Bio Specified
Jorge Conde is a General Partner at Andreessen Horowitz where he leads investments at the cross section of biology, computer science and health. Prior to joining a16z, Jorge served as Chief Strategy Officer for Syros (NASDAQ: SYRS), which is advancing a new wave of medicines that control expression of disease-driving genes to treat cancer and other diseases. He previously served as the company's Chief Financial Officer and Chief Product Officer, leading the platform strategy for Syros' novel gene regulation technology. Jorge also cofounded Knome, a human genome interpretation company acquired by Tute Genomics in 2015. Earlier in his career, Jorge worked in marketing and operations at MedImmune and as a biotechnology investment banker at Morgan Stanley. He is smart, hardworking, well connected , committed, very experienced and always there for his CEOs and companies.
No Education Specified
No classmates Specified
No Core Competencies Specified
No Greatest Attributes Specified
No Business Achievements Specified
No Worst Failures in Business Specified
No Political Party Specified